β¨ Medicines and Industrial Hemp Regulations
NEW ZEALAND GAZETTE, No. 105
7 SEPTEMBER 2006
3088
Product:
Dantrium
Active Ingredient:
Dantrolene sodium 50mg
Dosage Form:
Capsule, powder filled
New Zealand Sponsor:
Pfizer New Zealand Limited
Manufacturer:
Procter & Gamble Pharmaceuticals Puerto Rico Inc, Bo. Cotto Norte, Manati, Puerto Rico
Product:
Zantac Relief Extra Strength
Active Ingredient:
Ranitidine hydrochloride 336mg equivalent ranitidine 300mg
Dosage Form:
Tablet
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturer:
GlaxoSmithKline Australia Pty Limited, Boronia, Victoria, Australia
Dated this 31st day of August 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go6145
Renewal of Provisional Consent to the Distribution of New Medicines
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Orgalutran
Active Ingredient:
Ganirelix 0.5mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Pharmaco (NZ) Limited
Manufacturer:
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany
Note: This consent is valid for two years from 9 November 2006.
Product:
Tracleer
Active Ingredient:
Bosentan 125mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer:
Patheon Inc, Mississauga, Ontario, Canada
Note: This consent is valid for two years from 16 December 2006.\n
Product:
Tracleer
Active Ingredient:
Bosentan 62.5mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer:
Patheon Inc, Mississauga, Ontario, Canada
Note: This consent is valid for two years from 16 December 2006.
Product:
Ursofalk
Active Ingredient:
Ursodeoxycholic acid 250mg
Dosage Form:
Capsule
New Zealand Sponsor:
St Ives Medical
Manufacturer:
Losan Pharma GmbH, Neuenburg, Germany
Note: This consent is valid for two years from 28 October 2006.
Dated this 31st day of August 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go6146
Misuse of Drugs (Industrial Hemp) Regulations 2006
Schedule of Approved Cultivars of Industrial Hemp
Finola
Kompolti
USO31
Fasamo
Anka
Pursuant to Regulation 5 (1) of the Misuse of Drugs (Industrial Hemp) Regulations 2006, I, Stephen McKernan, Director-General of Health, hereby approve the cultivars of industrial hemp described below for the purposes of that Regulation.
Dated at Wellington this 21st day of August 2006.
STEPHEN McKERNAN, Director-General of Health.
go6107
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2006, No 105
Gazette.govt.nz —
NZ Gazette 2006, No 105
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare31 August 2006
Medicines, Distribution, Dantrium, Zantac Relief Extra Strength
- DON MATHESON, Deputy Director-General, Public Health
π₯ Renewal of Provisional Consent to the Distribution of New Medicines
π₯ Health & Social Welfare31 August 2006
Medicines, Provisional Consent, Orgalutran, Tracleer, Ursofalk
- DON MATHESON, Deputy Director-General, Public Health
π₯ Schedule of Approved Cultivars of Industrial Hemp
π₯ Health & Social Welfare21 August 2006
Industrial Hemp, Cultivars, Finola, Kompolti, USO31, Fasamo, Anka
- STEPHEN McKERNAN, Director-General of Health